Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse: a National Multi-centre Prospective Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Cap-assisted endoscopic sclerotherapy (CAES) is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. However, the long-term efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse are still not clear due to the lack of large sample studies. Therefore, a nationwide multi-center, large sample, prospective and cohort study was designed to evaluate the efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse, to provide reliable evidence for popularization of this minimally invasive technology.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Grade I-III internal hemorrhoids (with or without external hemorrhoids) or/and recal prolapse.

• Patients with bowel preparation.

Locations
Other Locations
China
Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University
RECRUITING
Nanjing
Contact Information
Primary
Faming Zhang, MD,PhD
fzhang@njmu.edu.cn
02558509884
Time Frame
Start Date: 2019-12-30
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 10000
Treatments
Internal hemorrhoids and rectal prolapse
Participants were treated with Cap-assisted endoscopic sclerotherapy (CAES).
Sponsors
Leads: Faming Zhang

This content was sourced from clinicaltrials.gov